Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, IL
A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects with Castration Resistant Prostate Cancer That Have Received Prior Treatment with Docetaxel.
The purpose of this study is to examine the safety and effectiveness (how well the drug works) of treatment with radiotherapy followed by an investigational compound (a drug that is not currently approved by the United States Food and Drug Administration [FDA] or any other health authority), ipilimumab (also known as MDS-010 or BMS-734016). The effectiveness of ipilimumab will be determined by looking at:
Please contact Alexian Brothers for more information on participation.
CW ID: 176857
Date Last Changed:
July 22, 2013
Alexian Brothers Hospital Network800 Biesterfield RoadElk Grove Village, IL 60007Phone: 847-952-7164
Research Center Information: Alexian Brothers Hospital Network
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.